Latest News
DeepIntent’s “Innovating with Intent” Summit Highlights the Future of CTV in Pharma
Leading ad tech innovators and thought leaders from companies including Publicis Health Media, LiveRamp, VAB, FreeWheel, DoubleVerify, LG Ads Solutions, and more joined DeepIntent …
DeepIntent Becomes First Demand Side Platform to Offer a Patient Reach Guarantee
Programmatic campaigns conducted on the DeepIntent platform are now guaranteed to reach verified patient audiences for specific health conditions across CTV, display, and digital …
Fluent Joins DeepIntent’s Audience Marketplace with Permissioned Data for Healthcare Marketers
Self-declared health and wellness data will enable more efficient cross-platform targeting initiatives NEW YORK, March 22, 2022 – Fluent, Inc., a leading data-driven, performance …
DeepIntent Expands Partnerships and Team to Lead Pharma’s Dramatic CTV Advertising Shift
Strategic Hires and Promotions, Industry-Leading Platform, and Exclusive Partnerships Support the Future of Pharmaceutical Marketing NEW YORK, March 8, 2022 — DeepIntent, the leading …
Connected TV works ‘harder and smarter’ for the ad dollar, new analysis finds
As more and more people flock to streaming channels over traditional TV, pharma ad dollars are following them. In this article for Fierce Pharma, …
Tapping new tech helps marketers matchmake rare disease drugs for elusive patients
Treating rare diseases is challenging enough, so you can imagine how difficult it is to reach the right healthcare audiences with info about specialty …
DeepIntent Receives Patent for Technology that Enables Marketers to Reach Precise Patient Populations in a HIPAA-Compliant, Privacy-Safe Manner
DeepIntent’s Patient Modeled Audiences Solution Uses Industry’s Most Comprehensive Real-World Clinical Datasets to Precisely Reach Patient Populations, Including Those Facing Rare Diseases and Low …
Pharma marketing 2022: More digital shifts for reps, ads and drug launches, plus reputation and the metaverse
What trends can healthcare marketers expect in 2022? In this article for Endpoints News, CEO Chris Paquette discusses how pharma brands will be increasing …
DeepIntent Outcomes™ Named by PM360 as One of the Most Innovative Products of 2021
NEW YORK, Dec. 13, 2021 — PM360, a leading trade magazine for marketing decision makers in the pharmaceutical, biotech, medical device, and diagnostics industries, …
